G01N 2800/202
Dermatitis
G01N2800/202 (Dermatitis) appears on 61 US grants and 135 published applications in this corpus.
Search patents in G01N- Granted patents
- 61
- Published applications
- 135
- Assignees
- 72
- Inventors
- 295
- Latest grant
- 24 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 3 |
| 2004 | 0 | 3 |
| 2005 | 0 | 2 |
| 2006 | 2 | 2 |
| 2007 | 3 | 5 |
| 2008 | 2 | 7 |
| 2009 | 0 | 5 |
| 2010 | 3 | 6 |
| 2011 | 8 | 13 |
| 2012 | 1 | 7 |
| 2013 | 8 | 7 |
| 2014 | 5 | 7 |
| 2015 | 7 | 9 |
| 2016 | 2 | 8 |
| 2017 | 5 | 3 |
| 2018 | 3 | 4 |
| 2019 | 1 | 5 |
| 2020 | 2 | 3 |
| 2021 | 1 | 3 |
| 2022 | 0 | 4 |
| 2023 | 3 | 10 |
| 2024 | 0 | 8 |
| 2025 | 3 | 5 |
| 2026 | 2 | 6 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Pharmaceutical composition for prevention, amelioration, or treatment of skin disease24 Mar 2026US 12,582,680 B2Keio University
- Treating atopic dermatitis by targeting the WNT pathway27 Jan 2026US 12,534,762 B2Children's Medical Center Corporation
- Methods for treating atopic dermatitis by administering an IL-4R antagonist23 Dec 2025US 12,502,429 B2Regeneron Pharmaceuticals, Inc.
- Compounds and methods targeting interleukin-194 Nov 2025US 12,459,997 B2Eli Lilly and Company
- Therapeutic mitigation of epithelial infection4 Mar 2025US 12,239,705 B2University of Rochester
- Collagen Type VI Alpha-6 Assay3 Sep 2026US 2026/0259223 A1Nordic Bioscience A/S
- Biomarkers for assessing the effect of drugs in pathological disorders30 Jul 2026US 2026/0219281 A1DermAb. io
- Method for detecting inflammatory skin disease and judging severity thereof16 Jul 2026US 2026/0202421 A1Nanoegg Research Laboratories, Inc.
- Methods for Treating Atopic Dermatitis by Administering an IL-4R Antagonist21 May 2026US 2026/0137778 A1Regeneron Pharmaceuticals, Inc.
- Compounds and methods targeting interleukin-197 May 2026US 2026/0125462 A1Eli Lilly and Company
Most cited
By later US patents
- Enzyme treatment of foodstuffs for Celiac Sprue47US 7,303,871 B2The Board of Trustees of the Leland Stanford Junior University · 2007
- Drug therapy for celiac sprue36US 7,202,216 B2The Board of Trustees of the Leland Stanford Junior University · 2007
- Peptides for diagnostic and therapeutic methods for celiac sprue34US 7,462,688 B2The Board of Trustees of the Leland Stanford Junior University · 2008
- Tape stripping methods for analysis of skin disease and pathological skin state32US 7,183,057 B2DermTech International · 2007
- Enzyme treatment of foodstuffs for celiac sprue26US 7,943,312 B2The Board of Trustees of the Leland Stanford Junior University · 2011